BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10487252)

  • 1. Update on the diagnosis and treatment of social anxiety disorder.
    Liebowitz MR
    J Clin Psychiatry; 1999; 60 Suppl 18():22-6. PubMed ID: 10487252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of separation, generalized, and social anxiety disorders in youths.
    Mohatt J; Bennett SM; Walkup JT
    Am J Psychiatry; 2014 Jul; 171(7):741-8. PubMed ID: 24874020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomised controlled trial].
    Schadé A; Marquenie LA; van Balkom AJ; Koeter MM; van den Brink W; van Dyck R
    Tijdschr Psychiatr; 2008; 50(3):137-48. PubMed ID: 18324601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder.
    Berger P; Sachs G; Amering M; Holzinger A; Bankier B; Katschnig H
    J Affect Disord; 2004 May; 80(1):75-8. PubMed ID: 15094260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric anxiety disorders: management in primary care.
    Sakolsky D; Birmaher B
    Curr Opin Pediatr; 2008 Oct; 20(5):538-43. PubMed ID: 18781116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder.
    Book SW; Thomas SE; Randall PK; Randall CL
    J Anxiety Disord; 2008; 22(2):310-8. PubMed ID: 17448631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment.
    Brunello N; den Boer JA; Judd LL; Kasper S; Kelsey JE; Lader M; Lecrubier Y; Lepine JP; Lydiard RB; Mendlewicz J; Montgomery SA; Racagni G; Stein MB; Wittchen HU
    J Affect Disord; 2000 Oct; 60(1):61-74. PubMed ID: 10940449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and treatment of anxiety disorders in children and adolescents.
    Wehry AM; Beesdo-Baum K; Hennelly MM; Connolly SD; Strawn JR
    Curr Psychiatry Rep; 2015 Jul; 17(7):52. PubMed ID: 25980507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety Disorders: A Review.
    Szuhany KL; Simon NM
    JAMA; 2022 Dec; 328(24):2431-2445. PubMed ID: 36573969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social anxiety disorder/social phobia: epidemiology, diagnosis, neurobiology, and treatment.
    den Boer JA
    Compr Psychiatry; 2000; 41(6):405-15. PubMed ID: 11086145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why take social anxiety disorder seriously?
    Lépine JP; Pélissolo A
    Depress Anxiety; 2000; 11(3):87-92. PubMed ID: 10875048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WCA recommendations for the long-term treatment of social phobia.
    Van Ameringen M; Allgulander C; Bandelow B; Greist JH; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; Swinson RP;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):40-52. PubMed ID: 14767397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social anxiety disorder.
    Stein MB; Stein DJ
    Lancet; 2008 Mar; 371(9618):1115-25. PubMed ID: 18374843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating neurobiology and psychopathology into evidence-based treatment of social anxiety disorder.
    Liebowitz MR; Ninan PT; Schneier FR; Blanco C
    CNS Spectr; 2005 Oct; 10(10):suppl13 1-11; discussion 12-3; quiz 14-5. PubMed ID: 16404800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and therapeutic characteristics of social phobia in French psychiatry (Phoenix study)].
    Pélissolo A; Huron C; Fanget F; Servant D; Stiti S; Richard-Berthe C; Boyer P
    Encephale; 2006; 32(1 Pt 1):106-12. PubMed ID: 16633297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.